文献速递心肺康复

COPD患者肺康复后Brief-BESTest的反应性与最小临床重要差异

Responsiveness and Minimal Clinically Important Difference of the Brief-BESTest in People With COPD After Pulmonary Rehabilitation.
PubMed 文献 · Phys Ther · 2021-01-01

结果显示Brief-BESTest改善3分(SD=3),合并MCID为3.3分,提示至少改善3分可增强肺康复对平衡功能效果的解释性。

要点

  • COPD患者12周肺康复后Brief-BESTest平均改善3分(SD=3)。
  • Brief-BESTest的合并MCID为3.3分,锚定法与分布法按2/3与1/3加权计算。
  • Brief-BESTest与mMRC(r=-.31)和6分钟步行试验(r=.37)显著相关。

核心结论

  • COPD患者肺康复后Brief-BESTest改善至少3分可增强对平衡功能效果的解释性,并指导个体化干预。

研究设计与样本

  • 患者在12周含平衡训练的肺康复前后接受Brief-BESTest(0-24分)、6分钟步行试验和mMRC评估。

主要发现

  • 肺康复后Brief-BESTest显著改善,平均差异为3分(SD=3)。
  • Brief-BESTest与mMRC显著相关(r=-.31),与6分钟步行试验显著相关(r=.37)。
  • 采用锚定法和分布法计算的合并MCID为3.3分。

关键数值与推荐

  • Brief-BESTest评分范围0-24分,肺康复后改善至少3分视为具有临床意义。
  • 合并MCID为3.3分,由2/3锚定法和1/3分布法经算术加权平均计算。

临床怎么用

  • 临床可用Brief-BESTest评估COPD患者肺康复前后的平衡功能变化。
  • 以改善至少3分作为判断肺康复对平衡功能有临床意义效果的参考阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: he Brief-Balance Evaluation Systems Test (Brief-BESTest) is a comprehensive, reliable, and valid balance test that provides valuable information to guide balance training in people with chronic obstructive pulmonary disease (COPD). Its clinical interpretability is, however, currently limited, because cutoff points to identify clinically relevant changes in people with COPD after pulmonary rehabilitation are still lacking. This study aimed to establish the responsiveness and minimal clinically important difference (MCID) for the Brief-BESTest in people with COPD after pulmonary rehabilitation (PR). METHODS: A secondary analysis of data from 2 previous studies was conducted. The modified British Medical Research Council (mMRC) dyspnea scale, the 6-Minute Walk Test (6-MWT), and the Brief-BESTest (0-24 points) were collected in people with COPD pre/post a 12-week PR program including balance training. The MCID was computed using anchor- and distribution-based methods. Changes in the 6-MWT and the mMRC were assessed and used as anchors. The pooled MCID was computed using the arithmetic weighted mean (2/3 anchor- and 1/3 distribution-based methods). RESULTS: Seventy-one people with COPD (69 years [SD = 8]; 76% male; FEV1 = 49.8%predicted [SD = 18%]) were included. There was a significant improvement in the Brief-BESTest after PR (mean difference = 3 points [SD = 3]). Significant correlations were found between the Brief-BESTest and the mMRC (r = -.31) and the 6-MWT (r = .37). The pooled MCID was 3.3 points. CONCLUSION: An improvement of at least 3 points in the Brief-BESTest in people with COPD will enhance the interpretability of PR effects on balance performance of this population and guide tailored interventions. IMPACT: The Brief-BESTest outcome measure is comprehensive, easily administered, and simple to interpret in clinical practice. This study represents a significant contribution toward the clinical interpretation of changes in balance in people with COPD following PR.

来源:Phys Ther,查看原文。版权归原作者所有。

引用

  1. Paixão C, Rebelo P, Oliveira A, et al. Responsiveness and Minimal Clinically Important Difference of the Brief-BESTest in People With COPD After Pulmonary Rehabilitation. Phys Ther. 2021. PMID: 34499161. doi:10.1093/ptj/pzab209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。